What’s Hot, Not & Doing
Brought to you by TSN Contributor & Wealth Advisor Nick Kelso
What’s Hot – MTC, CTT, MQR, KLI, CRD, NIM, HYT, RKT & IMU
What’s Not – MDR
What’s Hot
MTC – MetalsTech Limited today closed up 44% to finish at 26c on $1m stock traded. The reason they were up today was because they announced a group of shareholders have executed various sale agreements to sell 35.2m shares & 5m performance rights.
The shares were purchased by a significant private mining investor at 53c per share which values the transaction at $18.5m for a ~17.9% interest.
One of the sellers is an entity controlled by Mr Gino D’Anna, an executive director of MTC, whilst the other sellers are both entities controlled by Ms Fiona Paterson.
CTT – Cettire Limited today closed up 34% to finish at $1.405 on $18m stock traded. There was no news out today but last week they released its preliminary full year results which revealed a 34% decline in net profit after tax (NPAT) to $10.47m.
Notwithstanding the impact of increased growth investment, Cettire achieved full year adjusted EBITDA growth of 11% to $32.5 million and increased its delivered margin by 62% to $155m.
Since the start of FY25, the global luxury sector has continued to experience softer trading conditions.
MQR – Marquee Resources Limited today closed up 33% to finish at 1.8c on $480k stock traded. The reason they were up today was because they announced a significant antimony structural trend was identified at its Mt Clement (Eastern Hills) Project located in WA.
MQR’s project immediately abuts the Mt Clement Antimony-Lead Deposit owned by Black Cat Syndicate (BC8.asx) which currently contains a maiden JORC compliant resource of 13.2kt @ 1.7% Sb (plus 18.7kt Pb, 7Koz AU and 434Koz Ag).
The Taipan structural trend extends for a further 800m onto Marquee’s ground, but the area has had little to no exploration and thus remains open for the identification of further antimony bearing zones.
KLI – Killi Resources Limited today closed up 31% to finish at 17c on $1.5m stock traded. There was no news out today but roughly a fortnight ago they announced drilling had commenced at its Kaa copper-gold target within its Mt Rawdon West Project located in QLD.
Last month, KLI announced a new epithermal gold system was exposed at surface with rock chip assays returning up to 238g/t Au, 2.1% Cu & 513g/t Ag.
A recently completed IP Survey had also identified multiple chargeable (sulphide-rich) and resistive (silica-rich) responses beneath the ridge and undercover.
CRD – Conrad Asia Energy Limited today closed up 26% to finish at $1.14 on $850k stock traded. The reason they were up today was because they announced a gas sale agreement (GSA) was signed with Sembcorp for its 76.5% owned Mako Gas Field (Duyung PSC) located in Indonesia.
Sembcorp Gas is a wholly owned subsidiary of Sembcorp Industries (A$9.85b market cap), it is Indonesia’s largest gas company.
The contract term is until the end of Duyung PSC in January 2037 and allows for the sale of up to 76.9m standard cubic feet per day (mmscfd).
The Mako field contains 2C Contingent Resources of 376 billion cubic feet (Bcf) and is scheduled to begin production in 2026.
NIM – Nimy Resources today closed up another 18% to finish at 10c on $210k stock traded. There was no news out today but last Wednesday they announced assay results from the Masson target within its Mons Project located in WA.
Last month, NIM intersected a 10m interval of massive and disseminated sulphide mineralisation from 128m to 138m downhole.
Drilling has extended the mineralisation downhole to 274.5m from 102m and remains open, previous drilling established a mineralised north – south strike length of 160m, open in both directions.
The final diamond hole at Masson is underway and expected for completion early next week (this week), the hole is designed to further test dip and depth of mineralisation.
HYT – HyTerra Limited today closed up 12% to finish at 4.6c on $1.3m stock traded. There was no news out today but last week they announced Fortescue Future Industries Technologies (subsidiary of FMG) invested $21.9m @ 3.4c for a 39.8% interest in the company.
The investment represented a 9.6% premium to the last closing price of 3.1c, FMG will also be issued 322m options which are exercisable at 5.1c.
The proceeds will fully fund an expanded initial exploration phase of the Nemaha Project facilitating a significant increase in pre-drill acreage, resulting in increased drilling of prospects in several identified geological play areas.
RKT – RocketDNA Limited today closed up 11% to finish at 1c on $190k stock traded. The reason they were up today was because they announced the signing of two significant contracts for its xBot surveillance model (PatrolBot) with SSG Security Solutions.
The PatrolBot system is a cutting-edge, autonomous surveillance solution designed to continuously secure critical perimeters and monitor assets.
These two contracts involve the deployment of PatrolBot units across a number of mining sites for the monitoring and reporting of defined areas using drone or unmanned technology for the purpose of security overwatch and intelligence gathering.
IMU – Imugene Limited today closed up 10% to finish at 6.8c on $23m stock traded. The reason they were up today was because they announced results from its Phase 1b clinical trial with azer-cel (azercabtagene zapreleucel, an allogeneic off-the-shelf CD19 CAR T), in patients with relapsed/refractory diffuse large B cell lymphoma (DLBCL).
DLBCL is an aggressive and fast-growing type of non-Hodgkin’s lymphoma (NHL), a type of blood cancer with approximately 80,500 cases per year.
There have been 10 patients which have been treated to date with azer-cel in the Phase 1b diffuse large B-cell lymphoma (DLBCL) trial, cohort A was with chemotherapy and cohort B was with chemotherapy and interleukin 2 (IL-2).
What’s Not
MDR – MedAdvisor Solutions Limited today closed down 10% to finish at 40c on $1.7m stock traded. There was no news out today but last week they released its annual results which highlighted a 24.6% increase in revenue to $122.1m.
EBITDA improved from a loss of $3m in FY23 to a profit of $7m while net profit after tax improved from a loss of $11.3m to a gain of $800k.
MDR’s 5-year strategic plan is targeting a 20-25% compounding annual growth rate (CAGR) in group revenue and EBITDA margins greater than 20%.
Back on Friday, MDR had its price target cut by 3.1% by Bell Potter to 62c per share which may have spooked a few shareholders.
Rats Rant – IMPORTANT INFORMATION
The idea of this report is to be informative and hopefully point out some stocks that you wouldn’t ordinarily have seen during the day, maybe even have a laugh too.This report IS NOT personal advice. Sanlam Private Wealth Pty Ltd DOES NOT PROVIDE personal advice, Sanlam Private Wealth provides General Financial Product Advice.All advice included in The Rat’s Rant is General Advice. Please refer to the General Advice Warning. The views expressed in this report are my views and may not necessarily reflect the same views as Sanlam Private Wealth.It is very important to refer to the ASX website for information on any companies / stock that are contained in this report and as always please consult your financial adviser before acting.
Important Notice
Rat Consulting Pty Ltd (ABN 81 148 181 588 ) Authorised Representative (No 001281456) of Sanlam Private Wealth Ltd (ABN 18 136 960 775) holder of Australian Financial Services Licence (AFSL 337 927).